Strides Pharma Science LtdNSE: STAR

Press Release Sep 01 2022

· Issued by Strides Pharma Science Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-01-2022-15

Strides Pharma Science Limited has informed the Exchange about press release dated 01-Sep-2022 titled Stelis Biopharma���s flagship facility receives USFDA nod for Drug Product Capabilities

View Attachment

6ix hasn’t read this filing yet.

Strides Pharma Science Ltd on 6ix

Earlier from Strides Pharma Science

Later from Strides Pharma Science

All Strides Pharma Science news releases